Enliven Therapeutics, Inc. ($ELVN)
Filing Information
| Accession Number | 0001967150-26-000001 |
|---|---|
| Form Type | 4 |
| Filing Date | Jan 12, 2026 |
| Document Date | Jan 8, 2026 |
| Document | View SEC Filing |
Transactions
4
Total Shares
132,500
Total Value
$3,476,013.95
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
CHIEF SCIENTIFIC OFFICER | Common Stock | โ | Jan 8, 2026 | Sale | 7,500 | $20.13 | $150,961.50 | 890,188 | Indirect | See footnote | View Details | |
CHIEF SCIENTIFIC OFFICER | Common Stock | โ | Jan 8, 2026 | Sale | 33,802 | $24.92 | $842,474.29 | 856,386 | Indirect | See footnote | View Details | |
CHIEF SCIENTIFIC OFFICER | Common Stock | โ | Jan 9, 2026 | Sale | 41,198 | $24.90 | $1,025,863.16 | 815,188 | Indirect | See footnote | View Details | |
CHIEF SCIENTIFIC OFFICER | Common Stock | โ | Jan 9, 2026 | Sale | 50,000 | $29.13 | $1,456,715.00 | 765,188 | Indirect | See footnote | View Details |